The Dual Prevention Pill (DPP), which co-formulates oral pre-exposure prophylaxis (PrEP) and combined oral contraception in a single pill, could receive regulatory approval by 2025 and become the first multi-purpose prevention technology (MPT) with PrEP available. Planning for DPP implementation requires integrating best practices from PrEP and contraceptive provision to deliver an MPT, as integrating PrEP and family planning (FP) services has historically been a challenge.

This session will look at lessons from PrEP and FP implementation and scale-up to explore optimal implementation strategies for the DPP. Presenters will discuss potential scenarios for integrating the DPP in HIV prevention and FP provision, including approaches to reach and support different user segments, particularly young women; what healthcare providers will need to do differently to deliver an MPT; and the key questions, populations, and settings that implementation science studies on the DPP could focus on. Discussion will chart a way forward for DPP delivery.